Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1016/j.arabjc.2021.103631

http://scihub22266oqcxt.onion/10.1016/j.arabjc.2021.103631
suck pdf from google scholar
34909055!8662835!34909055
unlimited free pdf from europmc34909055    free
PDF from PMC    free
html from PMC    free
PDF vom PMID34909055 :   free

suck abstract from ncbi

pmid34909055
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Development of superior antibodies against the S-protein of SARS-Cov-2 using macrocyclic epitopes #MMPMID34909055
  • Traboulsi H; Khedr MA; Elgorashe R; Al-Faiyz Y; Negm A
  • Arab J Chem 2022[Mar]; 15 (3): 103631 PMID34909055show ga
  • One of the proven methods to prevent and inhibit viral infections is to use antibodies to block the initial Receptor Binding Domain (RBD) of SARS-CoV-2 S protein and avoid its binding with the host cells. Thus, developing these RBD-targeting antibodies would be a promising approach for treating the SARS-CoV-2 infectious disease and stop virus replication. Macrocyclic epitopes constitute closer mimics of the receptor's actual topology and, as such, are expected to be superior epitopes for antibody generation. This work demonstrated the vital effect of the three-dimensional shape of epitopes on the developed antibodies' activity against RBD protein of SARS-CoV-2. The molecular dynamics studies showed the greater stability of the cyclic epitopes in comparison with the linear counterpart, which was reflected in the activity of their produced antibodies. Indeed, the antibodies we developed using macrocyclic epitopes showed superiority with respect to binding to RBD proteins compared to antibodies formed from a linear peptide. The results of the present work constitute a roadmap for developing superior antibodies that could be used to inhibit the activity of the SARS-CoV-2 and prevent its reproduction.
  • ä


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    103631 3.15 2022